¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"major histocompatibility system"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® labium major ÇÑ±Û ´ëÀ½¼ø
¼³¸í   
  ¿©¼ºÀÇ ¼º±â °¡Àå ¹Ù±ùÂÊ¿¡ ÇØ´çÇϴ ºÎºÐ.
¿µ¹® hepatic portal system ÇÑ±Û °£¹®¸Æ°è
¼³¸í   
  À§, ÀÛÀºÃ¢ÀÚÀ̳ª Å«Ã¢ÀÚ¿¡¼­ ¿µ¾çºÐÀ» Èí¼öÇϱâ À§ÇÑ ¸ð¼¼Ç÷°üÁ¶Á÷Àº ¸ðµÎ °£À¸·Î ¿¬°áµÈ´Ù. Áï ¼ÒÈ­±â¿¡ Èí¼öÇÑ ¿µ¾çºÐÀÌ °¡µæÇÑ ÇǴ ¸ðµÎ °£À¸·Î ¿¬°áµÇ´Âµ¥ À̰ÍÀ» ¹®¸Æ°è¶ó°í ÇÑ´Ù.
¿µ¹® system ÇÑ±Û °è, °èÅë
¼³¸í   
  ÀÎü¸¦ ±¸¼ºÇϴ °è´Â ´ÙÀ½°ú °°ÀÌ ±¸ºÐµÈ´Ù.
  
  1) ½ÉÀåÇ÷°ü°èÅë(cardiovascular system)
  
  2) È£Èí±â°è(respiratory system)
  
  3) ¼ÒÈ­±â°è(digeshive system)
  
  4) ºñ´¢±â°è(urinary system)
  
  5) »ý½Ä±â°è(genital system)
  
  6) Ç÷¾×°è(hematologic system)
  
  7) ³»ºÐºñ°è(endocrine system)
  
  8) ½Å°æ°è(nervous system)
  
  9) °ñ°Ý°è(skeletal system)
  
  10) ±ÙÀ°°è(muscular system)
  
  11) ÇǺΰè(integumentary system).
¿µ¹® sympathetic nervous system ÇÑ±Û ±³°¨½Å°æ°è
¼³¸í   
  ÀÚÀ²½Å°æ°èÀÇ ÀÏÁ¾À¸·Î ³»Àå±â´ÉÀ» ÁַΠÇ×Áø½ÃÄѠȰµ¿À» Áõ°¡½Ã۴ ±â´ÉÀ» °¡Áø´Ù. ÀÚÀ²½Å°æ°èÀÇ ´Ù¸¥ °è¿­ÀΠºÎ±³°¨½Å°æ°è´Â ¹Ý´ë·Î ³»Àå±â´ÉÀ» ¾ïÁ¦½ÃÄÑ ¿¡³ÊÁö¸¦ ºñÃàÇϴ ±â´ÉÀ» °¡Áø´Ù. ÀÚÀ²½Å°æ°èÀÇ ÇØºÎÇÐÀû Æ¯¼ºÀº ½Å°æÀÌ ÁßÃ߽Űæ°è¿¡¼­ ³ª¿Í ¸ñÇ¥Àå±â¿¡ µµ´ÞÇϱâ Àü¿¡ ÇѹøÀÇ ½Ã³À½º(synapse)¸¦ ÀÌ·é´Ù´Â Á¡À̸ç, µû¶ó¼­ ÀÚÀ²½Å°æ°è´Â µÎ °³ÀÇ ½Å°æ(½Ã³À½º¸¦ ÀÌ·ç±â ÀüÀÇ ÀýÀü½Å°æ°ú ÀÌ·é ÈÄÀÇ ÀýÈĽŰæ)À¸·Î ±¸¼ºµÈ´Ù. ÀÚÀ²½Å°æ°èÁß ±³°¨½Å°æ°è´Â ÁßÃ߽Űæ°è Áï Ã´¼ö ºÎ±ÙÀÇ ±³°¨½Å°æÀý(sympathetic ganglion)¿¡¼­ ½Ã³À½º°¡ ÀϾ°í, ºÎ±³°¨ ½Å°æ°è´Â ÁßÃ߽Űæ°è¿¡¼­ ¸Ö¸® ¶³¾îÁø ¸ñÇ¥ Àå±âºÎ±ÙÀÇ ½Å°æÀý(ganglion)¿¡¼­ ½Ã³À½º°¡ ÀϾ´Â Á¡ÀÌ ´Ù¸£´Ù.
¿µ¹® musculoskeletal System ÇÑ±Û ±Ù°ñ°Ý°è
¼³¸í   
  ±ÙÀ°°ú À̵頱ÙÀ°ÀÌ ºÙ¾î¼­ °°À̠Ȱµ¿À» ¼öÇàÇϴ °ñ°Ý(»À¸¦ ÅëÅо»ÇÔ)À» ÇÔ²² ºÎ¸£´Â ¸». µû¶ó¼­ ¿©±âÀÇ ±ÙÀ°Àº ¸ðµÎ °¡·Î¹«´Ì±Ù¿¡ ¼ÓÇϸç, ¼öÀÇÀûÀ¸·Î ¿òÁ÷ÀÏ ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • major histocompatibility system
    ÁÖÁ¶Á÷ÀûÇÕ°èÅë
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • major histocompatibility antigen
    ÁÖÁ¶Á÷ÀûÇÕ¼ºÇ׿ø
  • major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • major histocompatibility gene
    ÁÖÁ¶Á÷ÀûÇÕ¼ºÀ¯ÀüÀÚ
  • histocompatibility
    Á¶Á÷ÀûÇÕ¼º
  • histocompatibility antigen
    Á¶Á÷ÀûÇÕ¼ºÇ׿ø
  • histocompatibility complex
    Á¶Á÷ÀûÇÕ¼ºº¹ÇÕü
  • histocompatibility gene
    Á¶Á÷ÀûÇÕÇ׿øÀ¯ÀüÀÚ
  • histocompatibility locus
    Á¶Á÷ÀûÇÕÇ׿øÀ¯ÀüÀÚÀÚ¸®
  • histocompatibility typing test
    Á¶Á÷ÀûÇÕ¼ºÀ¯Çü°Ë»ç
  • human histocompatibility antigen
    »ç¶÷Á¶Á÷ÀûÇÕ¼ºÇ׿ø
  • minor histocompatibility complex
    ºÎÁ¶Á÷ÀûÇÕº¹ÇÕü
  • fonticulus major
    ¾Õ¼ý±¸¸Û, ´ëõ¹®
  • labium major
    ´ëÀ½¼ø
  • Leishmania major
    Å«¸®½´¸¸Æí¸ðÃæ
  • major basic protein
    ÁÖ¿ä±âÃʴܹéÁú, ÁÖ±âÀú´Ü¹éÁú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • major depression
    ÁÖ¿ä¿ì¿ïÁõ
  • major lymphatic drainage
    Áֿ串ÇÁÀ¯Ãâ
  • pectoralis major myocutaneous flap
    Å«°¡½¿±ÙÇÇÆÇ, ´ëÈä±ÙÇÇÆÇ
  • Leishmania major
    Å«¸®½´¸¸Æí¸ðÃæ
  • pectoralis major muscle
    Å«°¡½¿±Ù, ´ëÈä±Ù
  • major tranquilizer
    °­·Â½Å°æ¾ÈÁ¤Á¦
  • system analysis
    °èÅëºÐ¼®
  • system
    1.°è, °èÅë, ü°è, 2.ÀåÄ¡, 3.Á¦µµ,
  • Bethesta system
    º£Å×½ºÅ¸ºÐ·ù(¹ý)
  • biliary system
    ´ãµµ°è, ¾µ°³°èÅë
  • blood group system
    Ç÷¾×Çü±º
  • central nervous system
    ÁßÃ߽Űæ°è, ÁßÃ߽Űæ°èÅë
  • information system
    Á¤º¸Ã¼°è
  • lymphatic system
    ¸²ÇÁ°èÅë
  • nervous system
    ½Å°æ°è, ½Å°æ°èÅë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • major histocompatibility system
    ÁÖÁ¶Á÷ÀûÇÕ°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • major histocompatibility antigen
    ÁÖÁ¶Á÷ÀûÇÕÇ׿ø
  • major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • major histocompatibility gene
    ÁÖÁ¶Á÷ÀûÇÕ¼ºÀ¯ÀüÀÚ
  • histocompatibility antigen
    Á¶Á÷ÀûÇÕÇ׿ø
  • human histocompatibility antigen
    »ç¶÷Á¶Á÷ÀûÇÕÇ׿ø
  • minor histocompatibility complex
    ºÎÁ¶Á÷ÀûÇÕº¹ÇÕü
  • histocompatibility gene
    Á¶Á÷ÀûÇÕÇ׿øÀ¯ÀüÀÚ
  • histocompatibility
    Á¶Á÷ÀûÇÕ
  • histocompatibility locus
    Á¶Á÷ÀûÇÕÇ׿øÀ¯ÀüÀÚÀÚ¸®
  • histocompatibility test
    Á¶Á÷ÀûÇÕ¼º°Ë»ç
  • major thymic bud
    Å«°¡½¿»ù½Ï
  • major calyx
    Å«ÄáÆÏÀÜ
  • major affective disorder
    ÁÖ¿äÁ¤µ¿Àå¾Ö, ÁÖ¿äÁ¤µ¿º´
  • major epilepsy
    ´ë°£Áú
  • major depressive episode
    ÁÖ¿ä¿ì¿ï»ðÈ­
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MHC => major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • antigen, major histocompatibility
    ÁÖÁ¶Á÷ÀûÇÕÇ׿ø, MHCÇ׿ø
  • histocompatibility antigen, major
    ÁÖÁ¶Á÷ÀûÇÕÇ׿ø
  • rectus capitis posterior major muscle ; muscle rectus capitis posterior major
    ´ëÈĵÎÁ÷±Ù(ÓÞý­ÔéòÁÐÉ).
  • T-tubular system =>transverse tubular system
    T-°è, °¡·Î¼Ò°ü °èÅë
  • H-Y histocompatibility antigen
    H-Y Á¶Á÷ÀûÇÕ¼º Ç׿ø
  • HLA= human leukocyte antigen ; histocompatibility antigens ; transplantation anti
    HLA<Á¶Á÷ÀûÇÕÀ̽Ä>Ç׿ø, »ç¶÷¹éÇ÷±¸Ç׿ø.
  • antigen, histocompatibility
    Á¶Á÷ÀûÇÕÇ׿ø
  • antigen,histocompatibility
    Á¶Á÷ÀûÇÕ¼º(ðÚòÄîêùêàõ)
  • histocompatibility
    Á¶Á÷ÀûÇÕ¼º
  • histocompatibility antigen
    Á¶Á÷ÀûÇÕÇ׿ø
  • histocompatibility antigens
    Á¶Á÷ÀûÇÕ Ç׿ø
  • histocompatibility gene
    Á¶Á÷ÀûÇÕ¼º À¯ÀüÀÚ
  • histocompatibility gene
    Á¶Á÷ÀûÇÕÀ¯ÀüÀÚ.
  • histocompatibility locus
    Á¶Á÷ÀûÇÕ¼º À¯ÀüÀÚÀÚ¸®, Á¶Á÷ÀûÇÕ¼º À¯ÀüÀÚÁÂ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • major histocompatibility system
    ÁÖÁ¶Á÷ ÀûÇÕ°è.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigen, major histocompatibility
    ÁÖÁ¶Á÷ÀûÇÕÇ׿ø, MHCÇ׿ø
  • complex, major histocompatibility
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • histocompatibility antigen, major
    ÁÖÁ¶Á÷ÀûÇÕÇ׿ø
  • major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕü.
  • major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕü(ñ«ðÚòÄîêùêô÷)
  • major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • major histocompatibility complex (MHC)
    ÁÖÁ¶Á÷ÀûÇÕü
  • major histocompatibility gene
    ÁÖÁ¶Á÷ÀûÇÕ¼º À¯ÀüÀÚ.
  • major palatine canal ; canalis palatinus major
    Å«±¸°³°ü, ´ë±¸°³°ü.
  • major palatine foramen ; foramen palatinum major
    Å«±¸°³±¸¸Û, ´ë±¸°³°ø.
  • major psoas muscle ; muscle psoas major
    Å«Ç㸮±Ù, ´ë¿ä±Ù(ÓÞé¦ÐÉ).
  • major psoas muscles ; musculus psoas major
    Å«Ç㸮±Ù, ´ë¿ä±Ù.
  • pectoralis major muscle ³ª musculus pectoralis major
    ´ëÈä±Ù.
  • rectus capitis posterior major muscle ; muscle rectus capitis posterior major
    ´ëÈĵÎÁ÷±Ù(ÓÞý­ÔéòÁÐÉ).
  • antigen, H-2 (histocompatibility)
    H-2 Ç׿ø (Á¶Á÷ÀûÇÕÇ׿øÀÇ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fornical system
    ³úȰ°èÅë
    [¿¾ ¿ë¾î] ³ú±Ã°è
  • Glial cell of peripheral nervous system
    ¸»ÃʾƱ³¼¼Æ÷
    [¿¾ ¿ë¾î] ¸»Ãʱ³¼¼Æ÷
  • Osteon [Harversian system]
    »À´ÜÀ§
    [¿¾ ¿ë¾î] °ñ¿ø
  • Genital system
    »ý½Ä°èÅë
    [¿¾ ¿ë¾î] »ý½Ä±â°èÅë
  • Cardiac conducting system
    ½ÉÀåÀüµµ°èÅë
    [¿¾ ¿ë¾î] ½ÉÀåÀÚ±ØÀüµµ°è
  • Conduction system of heart
    ½ÉÀåÀüµµ°èÅë
    [¿¾ ¿ë¾î] ½ÉÀåÀüµµ°è
  • CENTRAL NERVOUS SYSTEM
    ÁßÃ߽Űæ°èÅë
    [¿¾ ¿ë¾î] ÁßÃ߽Űæ°è
  • Glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁßÃß±³¼¼Æ÷
  • Renal system
    ÄáÆÏ°èÅë
    [¿¾ ¿ë¾î] ½ÅÀå°èÅë
  • Primitive duct system
    ¿ø½Ã°ü°èÅë
    [¿¾ ¿ë¾î] ¿ø½Ã°ü°èÅë
  • Labium major
    ´ëÀ½¼ø
    [¿¾ ¿ë¾î] ´ëÀ½¼ø
  • Forceps major [Occipital forceps]
    µÚÅë¼öÁý°Ô [Å«Áý°Ô]
    [¿¾ ¿ë¾î] ´ë°âÀÚ
  • Major renal calices
    Å«(ÄáÆÏ)¼úÀÜ
    [¿¾ ¿ë¾î] ´ë½Å¹è
  • Pectoralis major m.
    Å«°¡½¿±Ù
    [¿¾ ¿ë¾î] ´ëÈä±Ù
  • Major thymic bud
    Å«°¡½¿»ù½Ï
    [¿¾ ¿ë¾î] ´ëÈä¼±·Ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • major histocompatibility complex
    ÁÖ Á¶Á÷ÀûÇÕ º¹ÇÕü(ñ«ðÚòÄîêùêÜÜùêô÷)
  • histocompatibility
    Á¶Á÷ÀûÇÕ¼º(ðÚòÄîêùêàõ)
  • histocompatibility antigen
    Á¶Á÷ÀûÇÕ¼º Ç׿ø(ðÚòÄîêùêàõù÷ê«)
  • histocompatibility gene
    Á¶Á÷ ÀûÇÕ¼º À¯ÀüÀÚ(ðÚòÄîêùêàõë¶îîí­)
  • major gene
    ÁÖ À¯ÀüÀÚ(ñ«ë¶îîí­)
  • major groove
    ūȨ
  • major immunogene complex
    ÁÖ ¸é¿ªÀ¯ÀüÀÚ º¹ÇÕü(ñ«Øóæµë¶îîí­ÜÜùêô÷)
  • major-minor code
    ´ë.¼Ò(ÓÞá³)ÄÚµå
  • ABO blood group (type) system
    ABOÇ÷¾×Çü (úìäûúþ) ½Ã½ºÅÛ
  • absorption optical system
    Èí¼ö(ýåâ¥) ±¤ÇÐ(ÎÃùÊ) ½Ã½ºÅÛ
  • adiabatic system
    ´Ü¿­(Ó¨æð)½Ã½ºÅÛ
  • ATP regeneration system
    ATPÀç»ý(î¢ßæ) ½Ã½ºÅÛ
  • binding protein transport system
    °áÇÕ ´Ü¹éÁú ¼ö¼Û(Ì¿ùêÓ±ÛÜòõâÃáê) ½Ã½ºÅÛ
  • brain barrier system
    ³úÀ庮(Òàî¡Ûú) ½Ã½ºÅÛ
  • cell-free amino acid incorporating system
    ¹«¼¼Æ÷(Ùíá¬øà) ¾Æ¹Ì³ë»ê ÆíÀÔ(øºìý)¾¾½ºÅÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • major psoas muscle;muscle psoas major
    Å«Ç㸮±Ù, ´ë¿ä±Ù
  • histocompatibility
    Á¶Á÷ÀûÇÕ¼º
  • forceps major
    ´ë°âÀÚ
  • major
    ÁÖ¿äÀÇ, ´ë, Å«
  • major calyx
    Å«(½ÅÀå)¼úÀÜ, ´ë½Å¹è
  • major fissure
    ´ë¿­
  • major interlobar fissure
    ´ë¿±°£¿­
  • major operation
    ´ë¼ö¼ú
  • major surgery
    ´ë¼ö¼ú
  • pectoralis major muscle
    ´ëÈä±Ù
  • teres major muscle
    Å«¿ø±Ù, ´ë¿ø±Ù
  • array system
    ¹è¿­ÀåÄ¡, ¹è¿­Ã¼°è
  • cardiovascular system
    ½ÉÀåÇ÷°ü°è
  • central nervous system [=CNS]
    ÁßÃ߽Űæ°è(Åë)
  • CNS [=central nervous system]
    ÁßÃ߽Űæ°è(Åë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MHS major histocompatibility system; malignant hyperthermia in swine; malignant hyperthermia syndrome; m...
HLA histocompatibility leukocyte antigen; histocompatibility locus antigen; homologous leukocyte antibod...
MHC Major Histocompatibility Complex
HMC hand-mirror cell; health maintenance cooperative; heroin, morphine, and cocaine; histocompatibility ...
MHA major histocompatibility antigen; May-Hegglin anomaly; Mental Health Association; methemalbumin; mic...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MHC Anti-major histocompatibility complex
MHC Major Histocompatibility
MHC-II Major Histocompatibility Complex class II
MHC Major histocompatibility antigens
MHC-I Major histocompatibility complex class I
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • major histocompatibility complex
    ÁÖ Á¶Á÷ ÀûÇÕü, ÁÖ Á¶Á÷ ÀûÇÕ º¹ÇÕü
    ÀÎü Á¶Á÷ÇüÀ» °áÁ¤ÇÏ´Â À¯ÀüÀÚ°¡ 6¹ø ¿°»öüÀÇ ÀÛÀº ºÐÀý¿¡ º¹ÇÕü¸¦ Çü¼ºÇϰí À־ ÀÌ À¯ÀüÀÚ ¿µ¿ªÀ» À̸£´Â ¿ë¾î.
  • histocompatibility
    Á¶Á÷ ÀûÇÕ¼º
    Á¶Á÷ ÀûÇÕÀÇ ¼ºÁú ¶Ç´Â »óÅÂ.
  • histocompatibility gene
    Á¶Á÷ ÀûÇÕ À¯ÀüÀÚ, Á¶Á÷ ÀûÇÕ¼º À¯ÀüÀÚ
    ÀÌ½ÄµÈ Á¶Á÷À» ÀÚ±â Á¶Á÷ ¶Ç´Â ¿ÜºÎ Á¶Á÷À¸·Î ÀνÄÇÏ´Â À¯ÀüÀÚ.
  • histocompatibility testing
    Á¶Á÷ ÀûÇÕ¼º °Ë»ç
    Àå±â À̽Ľà Àå±â ¼ö¿©ÀÚ¿Í °ø¿©ÀÚ °£ÀÇ Á¶Á÷ÀÌ °ÅºÎ ¹ÝÀÀÀ» ÀÏÀ¸Å°Áö ¾Ê´ÂÁö¿¡ ´ëÇÑ °Ë»ç.
  • human histocompatibility antigen
    ÀÎü Á¶Á÷ ÀûÇÕ Ç׿ø
  • arteria palatina major
    Å« ±¸°³ µ¿¸Æ, ´ë±¸°³ µ¿¸Æ
    µ¿ÀǾî=greater
  • ductus pancreaticus major
    Å« ÃéÀå°ü, ´ëÃé°ü
  • fonticulus major
    ¾Õ ¼ý±¸¸Û, ´ëõ¹®
  • hysteria major
    ´ë È÷½ºÅ׸®
    ȯ¸ù »óÅÂ. È¥¹Ì ¹× ¸¶ºñ·Î µ¹¿¬ ¹ßº´ÇÏ´Â °ÍÀ» Ư¡À¸·Î ÇÏ´Â È÷½ºÅ׸®.
  • Leishmania major
    Å« ¸®½´¸¸ Æí¸ðÃæ
  • linguoplate major connector
    ¼³¸éÆÇ ÁÖ ¿¬°á ÀåÄ¡
    ¼³¸é ÆÇÀÇ ÇÑ ºÎºÐ.
  • major
    ´ë, ÁÖ, ÁÖ¿äÇÑ, ÁÖ¿äÀÇ, Å«
  • major amblyoscope
    ´ëÇü ¾à½Ã°æ, ´ëÇü ¾à½Ã°è
    ¾à½ÃÀÇ ´«À» ½Ã°¢¿¡ Âü¿©½Ã۵µ·Ï ÈÆ·Ã½ÃŰ°Å³ª ¶Ç´Â ¾ç¾ÈÀÇ À¶»ó·ÂÀ» ÃøÁ¤Çϰųª Áõ»ó½Ã۱â ÀÇÇÑ ±â°è.
  • major aphthae
    ´ë¾ÆÇÁŸ
  • major connector
    ÁÖ ¿¬°áÀÚ, ÁÖ ¿¬°á ÀåÄ¡
    1. ±¹¼Ò ÀÇÄ¡¿¡¼­ ¾Ç±Ã ÇÑÂÊ¿¡ ³õ¿©Áø º¸Ã¶¹°ÀÇ ÇÑ ºÎºÐ°ú ¹Ý´ëÂÊ¿¡ ³õ¿©Áø º¸Ã¶¹°ÀÇ ÇÑ ºÎºÐÀ» ¿¬°áÇÏ´Â ÀåÄ¡. 2. Ä¡±ÃÀÇ ÇÑÂÊ ±¸¼º ¿ä¼Òµé°ú ¹Ý´ëÆí ±¸¼º ¿ä¼ÒµéÀ» ¿¬°áÇØ ÁÖ´Â °¡Ã¶¼º ±¹¼Ò ÀÇÄ¡ÀÇ ÇÑ ºÎºÐÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
major histocompatibility antigen <immunology> A set of plasmalemmal glycoprotein antigens involved in rapid (e.g. 7 days in the mouse) graft rejection and other immune phenomena. The minor histocompatibility antigens are involved in much slower rejection phenomena. The major antigens show remarkable polymorphism and occur as Class I and Class II types in mammals, birds may have a Class III molecule as well.
See: histocompatibility antigens, MHC restriction.
(18 Nov 1997)
major histocompatibility complex The set of gene loci specifying major histocompatibility antigens, for example HLA in man, H 2 in mice, RLA in rabbits, RT 1 in rats, DLA in dogs, SLA in pigs, etc.
Acronym: MHC
(18 Nov 1997)
minor histocompatibility antigens Allelic alloantigens often responsible for weak graft rejection in cases when (major) histocompatibility has been established by standard tests. In the mouse they are coded by more than 500 genes at up to 30 minor histocompatibility loci. The most well-known minor histocompatibility antigen in mammals is the h-y antigen.
(12 Dec 1998)
minor histocompatibility loci Genetic loci responsible for the encoding of histocompatibility antigens other than those encoded by the major histocompatibility complex. The antigens encoded by these genes are often responsible for graft rejection in cases where histocompatibility has been established by standard tests. The location of some of these loci on the x and y chromosomes explains why grafts from males to females may be rejected while grafts from females to males are accepted. In the mouse roughly 30 minor histocompatibility loci have been recognised, comprising more than 500 genes.
(12 Dec 1998)
H2 histocompatibility <immunology> The ability of a tissue to be grafted from a donor to a host, without the host's immune system attacking the grafted tissue.
The chances of H2 histocompatibility is determined by how well the tissue proteins (cell surface glycoproteins in the tissue, to be specific) match between donor and host.
(09 Oct 1997)
histocompatibility If tissues of two organisms are histocompatible, then grafts between the organisms will not be rejected. If, however, major histocompatibility antigens are different then an immune response will be mounted against the foreign tissue.
(18 Nov 1997)
histocompatibility antigen <immunology> A set of plasmalemmal glycoproteins on the surface of all nucleated cells that are crucial for T-cell recognition of antigens. Particularly the HLA system in humans and the H2 system in mice. They are the major antigens responsible for tissue recognition. For this reason, they are of prime importance in determining compatible organ donors for a specific transplantation procedure. Each person has unique HLA antigens. Some HLA antigens have been identified to be correlated with the presence of certain autoimmune diseases. One of these is the HLA-B27 site. Approximately 85% of patients with ankylosing spondylitis and Reiter's syndrome will have the HLA-B27 antigen present on the leukocytes.
There are two classes of histocompatibility antigens:
1. Class I, histocompatibility antigens composed of two glycosylated subunits, a heavy chain of 44 kD and beta2 microglobulin (12 kD). The heavy chain may be coded by K, D or L genes of mouse H2 and A, B or C genes of human HLA complex. Class I antigens are important in T-cell killing and are recognised in conjunction with the foreign cell surface antigens MHC restriction).
2. Class II antigens, heterodimeric histocompatibility antigens composed of alpha (32 kD) and beta (28 kD) chains. Found mostly on B lymphocytes, macrophages and accessory cells. The response of T helper cells requires that the foreign antigen is presented in conjunction with the appropriate Class II antigens. (Murine H2 Ia antigens and human HLA DR antigens are Class II).
(14 Oct 1997)
histocompatibility antigens A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection.
(12 Dec 1998)
histocompatibility antigens class I Large transmembrane, polymorphic glycoproteins noncovalently associated with nonpolymorphic beta 2-microglobulin. In humans, three structural genes on chromosome 6 code for the HLA-a, HLA-b and HLA-c antigens. In mice, three genes named k, d, and l on chromosome 17 code for the h-2 antigens. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognised during graft rejection and restrict cell-mediated lysis of virus-infected cells. They are primarily associated with rheumatologic diseases and certain malignant disorders.
(12 Dec 1998)
histocompatibility antigens class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-d antigens and are coded by a gene on chromosome 6. In mice, two genes named ia and i.e. On chromosome 17 code for the h-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term ia antigens used to refer only to the proteins encoded by the ia genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen.
(12 Dec 1998)
histocompatibility complex A family of fifty or more genes on the sixth human chromosome that code for cell surface proteins and play a role in the immune response.Histocompatibility genes control the production of proteins on the outer membranes of tissue and blood cells, especially lymphocytes, and are vital elements in cell-cell recognition. The proteins also determine the level and type of immune response, and may serve other biochemical or immunologic functions. In the case of allografts, it is necessary to determine whether donor and recipient possess compatible sets of proteins (histocompatibility antigens), to minimise the likelihood of rejection. Histocompatibility testing (HLA tissue typing) provides this information.
(05 Mar 2000)
histocompatibility gene In laboratory animals, a gene which can elicit an immune response and thereby cause rejection of a homograft when tissue is transplanted from one individual to another; in humans, histocompatibility gene's control HLA antigens.
Synonym: H gene.
(05 Mar 2000)
histocompatibility testing Identification of the major histocompatibility antigens of transplant donors and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical abo blood group, and in addition should be matched as closely as possible for histocompatibility antigens in order to minimise the likelihood of allograft rejection.
(12 Dec 1998)
ala major ossis sphenoidalis Strong squamous processes extending in a broad superolateral curve from the body of the sphenoid bone. The greater wing presents these suraces (facies): 1) cerebral surface: forms anterior third of the floor of the lateral portions of the middle cranial fossa; 2) temporal surface: forms the deepest portion of the temporal fossa; 3) infratemporal surface, forms the "roof" of the infratemporal fossa; 4) orbital surface: forms posterolateral wall of orbit. The greater wing forms the inferior border of the supraorbital fissure, and is perforated at its root by foramina rotundum ovale, and spinosum and the pterygoid canal.
Synonym: ala major ossis sphenoidalis, ala temporalis.
(05 Mar 2000)
annulus iridis major The outer, broader of the two zones of the iris.
Synonym: annulus iridis major.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • major
    ÁÖµÈ,Å«ÂÊÀÇ,³ªÀ̰¡ ¸¹Àº,´Ù¼öÀÇ
  • Canis Major
    Å«°³ÀÚ¸®(the Great Dog)
  • Major Prophets
    (the ~ )(±¸¾à ¼º¼­ÀÇ) ´ë¿¹¾ð¼­;(Isaiah,Jeremiah,Ezekiel,DanielÀÇ 4¼­)(¶§·Î the m~ p~)´ë¿¹¾ð¼­ÀÇ ÀÛÀÚ
  • Ursa Major
    Å«°õÀÚ¸®
  • command sergeant major
    ºÎ´ë ÁÖÀÓ»ó»ç;ÁØÀ§
  • company sergeant major
    Áß´ë ¼±ÀÓ »ó»ç
  • drum major
    ¾Ç´ëÀÇ °í¼öÀå;¾ÇÀå
  • major
    (opp,minor) (µÑÁß¿¡¼­) Å«ÂÊÀÇ;´ëºÎºÐÀÇ;ÁÖ¿äÇÑ;ÀåÁ¶ÀÇ;¼º³âÀÇ;(M); (°°Àº ¼º¿¡¼­) ¿¬ÀåÀÇ(Brown ~ Å« ºê¶ó¿î)
  • major
    À°±º(ÇØ,°ø±º) ¼Ò·É;(Ư¹«) »ó»ç;(¹ý)¼º³âÀÚ;(³í)´ëÀüÁ¦;(¾Ç)ÀåÁ¶(A ~ °¡ÀåÁ¶);ÀåÀ½°è;(¹Ì) ´ëÇÐÀÇ Àü°ø°ú¸ñ
  • major
    (¹Ì) Àü°øÇÏ´Ù
  • major axis
    (¿øÃß °î¼±ÀÇ) ÀåÃà
  • major currency
    ÁÖ¿ä ÅëÈ­(´Þ·¯,¸¶¸£Å©,¿£ µî)
  • major general
    ¼ÒÀå(À°±º,ÇØº´,°ø±ºÀÇ)
  • major key
    ÀåÀ½°è;ÀåÁ¶
  • major key
    ÀåÁ¶
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á